Key Financial Data Of Group

Perseus Proteomics Inc. - Filing #7246108

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
Key financial data of group
Business results of group
Net sales
94,201,000 JPY
71,932,000 JPY
67,947,000 JPY
85,759,000 JPY
275,959,000 JPY
Ordinary profit (loss)
-689,604,000 JPY
-481,681,000 JPY
-410,107,000 JPY
-834,362,000 JPY
-145,545,000 JPY
Net assets
2,396,545,000 JPY
3,152,154,000 JPY
1,083,713,000 JPY
485,889,000 JPY
1,327,621,000 JPY
Total assets
2,566,650,000 JPY
3,300,530,000 JPY
1,118,626,000 JPY
547,889,000 JPY
1,360,169,000 JPY
Net assets per share
201.13
268.05
128.86
79.05
216.00
Basic earnings (loss) per share
-66.93
-54.47
-59.03
-136.95
-26.53
Diluted earnings per share
Equity-to-asset ratio
0.9215 xbrli:pure
0.9550 xbrli:pure
0.9661 xbrli:pure
0.8868 xbrli:pure
0.9761 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-564,274,000 JPY
-476,842,000 JPY
-422,836,000 JPY
-608,524,000 JPY
-329,661,000 JPY
Net cash provided by (used in) investing activities
-212,989,000 JPY
-33,868,000 JPY
-2,824,000 JPY
-3,409,000 JPY
-15,945,000 JPY
Net cash provided by (used in) financing activities
-20,000 JPY
2,647,548,000 JPY
1,011,040,000 JPY
JPY
JPY
Cash and cash equivalents
2,444,934,000 JPY
3,214,852,000 JPY
1,069,300,000 JPY
482,464,000 JPY
1,100,128,000 JPY
Number of employees
24 xbrli:pure
21 xbrli:pure
19 xbrli:pure
21 xbrli:pure
23 xbrli:pure
Average number of temporary employees
1 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.